Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics N.V (PRQR) Shares Outstanding (Diluted Average): 2022-2024

Historic Shares Outstanding (Diluted Average) for ProQR Therapeutics N.V (PRQR) over the last 3 years, with Dec 2024 value amounting to $92.0 million.

  • ProQR Therapeutics N.V's Shares Outstanding (Diluted Average) rose 37.29% to $123.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.2 million, marking a year-over-year increase of 37.29%. This contributed to the annual value of $92.0 million for FY2024, which is 4.98% up from last year.
  • According to the latest figures from FY2024, ProQR Therapeutics N.V's Shares Outstanding (Diluted Average) is $92.0 million, which was up 4.98% from $87.6 million recorded in FY2023.
  • ProQR Therapeutics N.V's Shares Outstanding (Diluted Average)'s 5-year high stood at $92.0 million during FY2024, with a 5-year trough of $73.1 million in FY2022.
  • In the last 3 years, ProQR Therapeutics N.V's Shares Outstanding (Diluted Average) had a median value of $87.6 million in 2023 and averaged $84.2 million.
  • Data for ProQR Therapeutics N.V's Shares Outstanding (Diluted Average) shows a peak YoY increased of 19.89% (in 2023) over the last 5 years.
  • ProQR Therapeutics N.V's Shares Outstanding (Diluted Average) (Yearly) stood at $73.1 million in 2022, then rose by 19.89% to $87.6 million in 2023, then increased by 4.98% to $92.0 million in 2024.